JAK to the Future: Advancing Alopecia Areata Care with Oral JAK Inhibitors

Featuring Natasha Mesinkovska, MD, PhD |

Vice Chair, Clinical Research 
University of California Irvine
Irvine, CA

, Carolyn Goh, MD |

Associate Clinical Professor of Medicine-Dermatology
UCLA David Geffen School of Medicine
Los Angeles, CA

, Mark Lebwohl, MD | Senior Clinical Advisor |

Dean for Clinical Therapeutics
Waldman Professor
Chairman Emeritus
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

| Published October 29, 2024

This session explores the latest clinical evidence on the efficacy and safety of oral JAK inhibitors for managing alopecia areata (AA), including criteria for patient selection, dose adjustment strategies, and shared decision-making approaches to enhance patient-centered care.